Terapias avanzadas en la cura del pie diabético: una revisión de la evidencia
Fecha
2017-05-20
Autores
Título de la revista
ISSN de la revista
Título del volumen
Editor
Jaén: Universidad de Jaén
Resumen
La prevalencia de diabetes se ha duplicado desde el año 1980 al 2016, pasando de un 4,7% al 8,5%. Se conoce que una de las más importantes afecciones de esta enfermedad es el síndrome de pie diabético, ocasionando discapacidad y morbilidad en los pacientes. El objetivo general de este estudio es identificar las terapias avanzadas en la cura del pie diabético y prevención de las amputaciones en los últimos diez años. Se han identificado diferentes terapias avanzadas como terapia hiperbárica de oxígeno (TOHB), terapia de presión negativa (NWPT), aplicación de injerto de piel (DG), aplicación de factor de crecimiento epidérmico (EGF), diferentes apósitos avanzados y otras terapias avanzadas comparándose con cuidados generales, la atención estándar 0 entre ellas. La mayoría de los
tratamientos avanzadas obtenidos se muestran a favor de la cura y prevención de amputaciones. La esencia para un adecuado cuidado de las heridas se consigue con la mezcla de cuidados generales y cuidados avanzados.
The prevalence of diabetes has increased from 1980 to 2016, rising from 4.7% to 85%. It is known that one of the most important conditions of this disease is diabetic foot syndrome, causing disability and morbidity in patients. The overall objective of this study is to identify advanced therapies ¡n diabetic foot healing and prevention of amputations in the last ten years. Different advanced therapies have been identified as hyperbaric oxygen therapy (HBOT), negative pressure therapy (NWPT), skin injection device (DG), epidermal growth factor (EGF), different advanced treatments and other advanced therapies compared with general care, standard care or between them. Most of the advanced treatments obtained are in favor of cure and prevention of amputations. There is no single therapy that is optimal for índividualized ulcer healing. The essence for appropriate wound care is achieved with the mix of general care and advanced care.
The prevalence of diabetes has increased from 1980 to 2016, rising from 4.7% to 85%. It is known that one of the most important conditions of this disease is diabetic foot syndrome, causing disability and morbidity in patients. The overall objective of this study is to identify advanced therapies ¡n diabetic foot healing and prevention of amputations in the last ten years. Different advanced therapies have been identified as hyperbaric oxygen therapy (HBOT), negative pressure therapy (NWPT), skin injection device (DG), epidermal growth factor (EGF), different advanced treatments and other advanced therapies compared with general care, standard care or between them. Most of the advanced treatments obtained are in favor of cure and prevention of amputations. There is no single therapy that is optimal for índividualized ulcer healing. The essence for appropriate wound care is achieved with the mix of general care and advanced care.